SynCardia Total Artificial Heart
When Both Sides of the Heart Need Support
Many mechanical circulatory support therapies are designed to assist a failing ventricle. The SynCardia Total Artificial Heart is designed for patients with end-stage biventricular heart failure who may require replacement of both ventricles when other support options may not meet their clinical needs.
For appropriate transplant-eligible patients, STAH can provide valuable time while awaiting a donor heart.
A Total Artificial Heart Designed for Advanced Heart Failure
The SynCardia Total Artificial Heart is an FDA-approved treatment option intended for transplant-eligible patients at risk of imminent death from biventricular failure.
The device replaces the failing ventricles and restores blood flow to the body and lungs while patients await heart transplantation.
Patients & Families
When treatment options become limited, understanding available therapies matters.
Physicians
A clinically proven option for carefully selected transplant candidates facing severe biventricular failure.
SynCardia is Here to Help
Interested in learning more about the SynCardia Total Artificial Heart or establishing a SynCardia Total Artificial Heart program at your hospital?
